Assignee
ONCOLMMUNIN INC
US·3 granted patents·4 pending applications·9 citations·filing 2001–2022
Top patents by PatentIndex Score
7 records- 0188US11261443B2In vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2019·Granted Mar 1, 2022·2 cites·16 claims
- 0276US10557136B2In vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2012·Granted Feb 11, 2020·2 cites·21 claims
- 0374US2022170017A1In vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2022·Application pending·0 cites
- 0462US7312302B2Compositions for the detection of enzyme activity in biological samples and methods of use thereofONCOLMMUNIN INC·Filed 2001·Granted Dec 25, 2007·5 cites·37 claims
- 0556US2016367587A1Systemic In Vivo Delivery of OligonucleotidesONCOLMMUNIN INC·Filed 2014·Application pending·0 cites
- 0655US2003211548A1Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markersONCOLMMUNIN INC·Filed 2003·Application pending·0 cites
- 0753US2023201361A1Targeted and localized in vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCOLMMUNIN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →